PPARGC1A and myalgic encephalomeyelitis/chronic fatigue syndrome: EA was also able to improve muscle strength by modulating AMPK/PGC-1α signaling in rats with chronic fatigue syndrome by reducing mitochondrial oxidative stress and increasing ATP synthesis (29).